ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Experts discuss the underutilization of biomarker testing in metastatic lung cancer, emphasizing the need for improved ...
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
Tovia Anyanwu, a kidney failure survivor, shares her shocking diagnosis after childbirth, her family's struggle, and how ...
The startup is developing a medicine that can very specifically degrade cancerous forms of EGFR, the target of several ...
The Cambridge, Massachusetts-based company – known as FogPharma until a rebrand in 2024 – needs cash for pivotal trials of ...
In the same week that Servier announced its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has ...
News Medical on MSN
Liquid Biopsies Boost Lung Cancer Mutation Detection
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for ...
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today ...
A 62-year-old woman with stage IIIA lung cancer faces complex diagnostic and treatment decisions, highlighting the importance ...
Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...
Rakuten Medical has added to its tally of mega-rounds, pocketing another $100 million to push its lead light-based cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback